Effects of behaviorally active ACTH (4–10) analogue – Semax on rat basal forebrain cholinergic neurons
The DOI matches its Crossref record.
Abstract
PURPOSE: It is well established that cholinergic neurons of the basal forebrain degenerate in Alzheimer's dementia. Although recent studies were concentrated on screening molecules that might reduce the concomitant cell loss, little is known about therapeutically promising molecules. We studied the effect of Semax (Met-Glu-His-Phe-Pro-Gly-Pro), a behaviorally active adrenocorticotropic hormone (4-10) analogue, on survival of cholinergic basal forebrain neurons in vitro. Semax is known to stimulate learning and memory and can be successfully used for treatment of ischemic stroke. METHODS: Primary cultures of neuronal and glial cells from basal forebrain of rats were used in all experiments. The stability of Semax in cell cultures was tested by HPLC analysis. Cell survival in neuronal cultures was quantitated using immocytochemical and cytochemical analyses as well as detection of choline acetyltransferase activity. RESULTS: We have shown that Semax may approximately 1.5-1.7 fold increase survival of cholinergic basal forebrain neurons in vitro. Moreover, Semax (100 nM) stimulated activity of choline acetyltransferase in dissociated basal forebrain tissue cultures. However, the numbers of GABA-ergic neurons, total neuron specific enolase neurons were not affected. In concentration from 1 nM to 10 microM, Semax did not affect proliferation of glial cells in primary cultures. CONCLUSION: Implications of these findings with respect to Alzheimer's disease remain to be clarified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cited by
Solid State Isotope Exchange with Spillover Hydrogen in Organic Compounds
Zolotarev, Y. A., Dadayan, A. K., Borisov, Y. А., et al. (2010) · Chemical Reviews · doi:10.1021/cr100053w · Cited by 35
Self-citationStavchansky, V. V., Yuzhakov, V. V., Botsina, A. Y., Skvortsova, V. I., Bondurko, L. N., Tsyganova, M. G., Limborska, S. A., Myasoedov, N. F., & Dergunova, L. V. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9421-2 · Cited by 34
“According to the literature, Semax has neuroprotective effects (Levitskaya et al. 2004; Grivennikov et al. 2008).”
BackgroundSelf-citationA New Generation of Drugs: Synthetic Peptides Based on Natural Regulatory Peptides
Kolomin, T., Shadrina, M., Slominsky, P., Limborska, S., & Myasoedov, N. (2013) · Neuroscience and Medicine · doi:10.4236/nm.2013.44035 · Cited by 30
“7 times and stimulated the activity of acetylcholinetransferase [54].”
BackgroundSelf-citationNeuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease
Khavinson, V. K., Ilina, A., Kraskovskaya, N., Linkova, N. S., Колчина, Н. В., Mironova, E. S., Erofeev, A., & Petukhov, M. (2021) · Pharmaceuticals · doi:10.3390/ph14060515 · Cited by 19
“Semax has nootropic, psycho-stimulating, antioxidant and antihypoxic effects [22–25].”
Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer’s Disease
Ilina, A., Khavinson, V., Linkova, N. S., & Petukhov, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084259 · Cited by 18
“The MEHFPGP peptide increased the survival of cholinergic neurons and stimulated choline acetyltransferase activity in dissociated cultures of neurons in the basal forebrain tissue [90].”
Background
Metadata
- Authors
- Grivennikov, I. A., Dolotov, O. V., Zolotarev, Y. A., Andreeva, L. A., Myasoedov, N. F., Leacher, L., Black, I. B., & Dreyfus, C. F.
- Affiliations
- Russian Academy of Sciences (RU)
- Institute of Molecular Genetics Russian Academy of Sciences, Kurchatov sq.2, 123182 Moscow, Russia
- Department of Neuroscience and Cell Biology UMDNJ/ Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854, USA
- ORCID
- Venue
- Restorative Neurology and Neuroscience
- Publisher
- SAGE Publications
- Published
- 2008-01-01
- Volume
- 26
- Issue
- 1
- Pages
- 35-43
- ISSN
- 0922-6028 (ISSN-L)
- 1878-3627
- OpenAlex
- W29947482
- Cited by
- 14
- References
- 0
- Citations by year
- 2022: 2 · 2021: 1 · 2020: 1 · 2018: 1 · 2016: 2 · 2015: 1 · 2013: 1 · 2012: 1
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Restorative Neurology and Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Semax, cholinergic neurons, basal forebrain, neuronal survival, Alzheimer's disease, choline acetyltransferase, neuroprotection, GABAergic neurons, neuron-specific enolase, glial cell proliferation, learning and memory
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Animals, Newborn, Cell Survival, Cells, Cultured, Choline O-Acetyltransferase, Dose-Response Relationship, Drug, gamma-Aminobutyric Acid, Gene Expression Regulation, Glial Fibrillary Acidic Protein, Neuroglia, Neurons, Peptide Fragments, Phosphopyruvate Hydratase, Time Factors, Prosencephalon, Neuroprotective Agents, Cell Proliferation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of behaviorally active ACTH (4–10) analogue – Semax on rat basal forebrain cholinergic neurons. https://app.cochat.ai/papers/10.3233/rnn-2008-00419
- The paper
- Grivennikov, I. A., Dolotov, O. V., Zolotarev, Y. A., Andreeva, L. A., Myasoedov, N. F., Leacher, L., Black, I. B., & Dreyfus, C. F. (2008). Effects of behaviorally active ACTH (4–10) analogue – Semax on rat basal forebrain cholinergic neurons. Restorative Neurology and Neuroscience. https://doi.org/10.3233/rnn-2008-00419
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.